Navegar por autor "Barreiro de Acosta, Manuel"

A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis

2014- Barreiro de Acosta, Manuel

A genome-wide association study identifies DSE-FAM26F as a risk locus for ulcerative colitis

2014- Barreiro de Acosta, Manuel

A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300

2013- Barreiro de Acosta, Manuel

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine

2011- Echarri Piudo, Ana; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Carracedo Álvarez, Ángel; Barros Angueira, Francisco; [et al.]

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)

2015- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio; [et al.]

Adalimumab dose escalation is effective for managing loss of response in Ulcerative Colitis

2015- Barreiro de Acosta, Manuel

Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

2015- Barreiro de Acosta, Manuel

Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease

2011- Barreiro de Acosta, Manuel

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

2011- Barreiro de Acosta, Manuel

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

2019- Bastida, G.; Marin-Jimenez, I.; Fores, A.; Garcia-Planella, E.; Arguelles-Arias, F.; [et al.]

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

2019- Chaparro, M.; Donday, M. G.; Barreiro de Acosta, Manuel; Domènech, E.; Esteve, M.; [et al.]

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model

2015- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Lorenzo González, Aurelio; Ferreiro Iglesias, Rocio; Uribarri González, Laura [et al.]

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis

2012- Echarri Piudo, Ana; Barreiro de Acosta, Manuel

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis

2011- Echarri Piudo, Ana; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Carracedo Álvarez, Ángel; Barros Angueira, Francisco; [et al.]

Cervical dysplasia and cancer in inflammatory bowel disease (IBD) women. Should we increase PAP test surveillance? A Spanish retrospective study

2013- Barreiro de Acosta, Manuel

Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease

2013- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique

Characteristics of inflammatory bowel disease (IBD) in a cohort of patients of Gypsy ethnicity

2011- Barreiro de Acosta, Manuel

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice

2015- Echarri Piudo, Ana; Ollero Pena, Virginia; Castro Alvariño, Javier; Barreiro de Acosta, Manuel; Lorenzo González, Aurelio [et al.]

Complementary and alternative medicine in inflammatory bowel disease patients. Is it a real problem?

2012- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Lorenzo González, Aurelio; Iglesias Rey, Marta [et al.]

Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors

2012- Barreiro de Acosta, Manuel; Domínguez Muñoz, Juan Enrique; Vallejo Senra, Nicolau; Lorenzo González, Aurelio

Repositorio digital RUNA

Navegar por autor "Barreiro de Acosta, Manuel"

A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis ﻿

A genome-wide association study identifies DSE-FAM26F as a risk locus for ulcerative colitis ﻿

A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300 ﻿

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine ﻿

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC) ﻿

Adalimumab dose escalation is effective for managing loss of response in Ulcerative Colitis ﻿

Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis ﻿

Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease ﻿

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab ﻿

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study) ﻿

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial ﻿

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model ﻿

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis ﻿

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis ﻿

Cervical dysplasia and cancer in inflammatory bowel disease (IBD) women. Should we increase PAP test surveillance? A Spanish retrospective study ﻿

Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease ﻿

Characteristics of inflammatory bowel disease (IBD) in a cohort of patients of Gypsy ethnicity ﻿

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice ﻿

Complementary and alternative medicine in inflammatory bowel disease patients. Is it a real problem? ﻿

Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors ﻿

A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis

A genome-wide association study identifies DSE-FAM26F as a risk locus for ulcerative colitis

A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300

A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine

Accuracy of a rapid fecal calprotectin test as a predictor of mucosal healing in patients with Ulcerative Colitis (UC)

Adalimumab dose escalation is effective for managing loss of response in Ulcerative Colitis

Adalimumab Dose Escalation Is Effective for Managing Loss of Response in Ulcerative Colitis

Adalimumab for pyoderma gangrenosum associated with inflammatory bowel disease

Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab

Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

Association between genotypes of bacteroidetes in fecal samples from patients with Crohn's disease and its assessment using an experimental mouse model

Candidate genes for azathioprine treatment response in inflammatory bowel disease patients using an exome-wide genotyping analysis

Candidate genes for azathioprine's efficacy or toxicity in inflammatory bowel disease patients using a exome-wide genotyping analysis

Cervical dysplasia and cancer in inflammatory bowel disease (IBD) women. Should we increase PAP test surveillance? A Spanish retrospective study

Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease

Characteristics of inflammatory bowel disease (IBD) in a cohort of patients of Gypsy ethnicity

Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice

Complementary and alternative medicine in inflammatory bowel disease patients. Is it a real problem?

Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors